After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Most recently, Yahoo Finance reported about the stock as it publicized that EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4).
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
EyePoint Pharmaceuticals Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. At the end of the last regular session, the stock closed at $23.98 and fluctuated between $24.89 as its day high and $21.77 as its day low. The current market capitalization of EyePoint Pharmaceuticals Inc is $846.73M. A total of 2.05 million shares were traded on the day, compared to an average of 1.50M shares.
Insider Activity
Insider trades are also considered as indicators of how a stock will perform in the future, in addition to stock predictions. During the recent three months, EYPT has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 16 BUYs and 23 SELLs from insiders. Insiders purchased 97,317 shares during that period but sold 870,129.
In the most recent transaction, Cormorant Asset Management, LP bought 750,000 shares of EYPT for 19.75 per share on Jan 11. After the transaction, the 10% Owner now owns 6,893,235 company shares. In a previous transaction on Jan 11, Ocumension Therapeutics sold 1,910,500 shares at 19.45 per share. EYPT shares that Director owns now total 100,221.
Among the insiders who sold shares, Liu Ye disposed of 1,910,500 shares on Jan 11 at a per-share price of $19.45. This resulted in the Director holding 100,221 shares of EYPT after the transaction. In another insider transaction, Cormorant Asset Management, LP bought 105,000 shares at $21.32 per share on Jan 09. Company shares held by the 10% Owner now total 6,143,235.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, EYPT has a high of $24.62 and a low of $2.21.
As of this writing, EYPT has an earnings estimate of $PYPT per share for the current quarter. EPS was calculated based on a consensus of EyePoint Pharmaceuticals, Inc. estimates, with a high estimate of $ENPT per share and a lower estimate of $VanEck Egypt Index ETF.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. EYPT’s latest balance sheet shows that the firm has $211.56M in Cash & Short Term Investments as of fiscal 2021. There were $39.20M in debt and $23.66M in liabilities at the time. Its Book Value Per Share was $1.66, while its Total Shareholder’s Equity was $184.38M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for EYPT is Buy with a score of 5.00.
